Detection of bladder cancer using single-photon emission computed tomography of thallium-201: a preliminary report

Anticancer Res. 2003 May-Jun;23(3C):2977-80.

Abstract

Thallium-201 (Tl-201) is a recognized tumor-imaging agent; however, the usefulness of Tl-201 in bladder cancer has not been studied. The aim of this preliminary study was to evaluate the potential usefulness of Tl-201 in detecting bladder cancer. A total of 14 patients (11 men and 3 women ranging in age from 49 to 80 years) with bladder cancer were arranged for Tl-201 single-photon emission computed tomography (SPECT) of the pelvis. All of the patients had transitional cell carcinoma (TCC). Meanwhile, 7 normal controls (5 men and 2 women; age range: 45-79 years) without any history of pelvic disease also accepted Tl-201 SPECT of the pelvis for comparison. In the result, Tl-201 pelvic SPECT detected bladder cancer in all 14 patients (100.0%). In contrast, all 7 normal controls (100.0%) had negative results of Tl-201 pelvic SPECT. Our study showed that the Tl-201 pelvic SPECT scan could be considered as a useful non-invasive imaging method in detection of bladder cancer.

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Aged, 80 and over
  • Carcinoma, Transitional Cell / diagnostic imaging*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Radiopharmaceuticals*
  • Thallium Radioisotopes*
  • Tomography, Emission-Computed, Single-Photon
  • Urinary Bladder Neoplasms / diagnostic imaging*

Substances

  • Radiopharmaceuticals
  • Thallium Radioisotopes